|
1
|
D’Andrilli G, Bovicelli A, Paggi MG and
Giordano A: New insights in endometrial carcinogenesis. J Cell
Physiol. 227:2842–2846. 2012.PubMed/NCBI
|
|
2
|
Amant F, Moerman P, Neven P, Timmerman D,
Van Limbergen E and Vergote L: Endometrial cancer. Lancet.
366:491–505. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Hogberg T, Signorelli M, de Oliveira CF,
et al: Sequential adjuvant chemotherapy and radiotherapy in
endometrial cancer - results from two randomised studies. Eur J
Cancer. 46:2422–2431. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Horan TC, Zompa MA, Kim CTSKK, et al:
Description of the cytotoxic effect of a novel drug
abietyl-isothiocyanate on endometrial cancer cell lines. Invest New
Drug. 30:1460–1470. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Chen YW, Lin GJ, Chia WT, Lin CK, Chuang
YP and Sytwu HK: Triptolide exerts anti-tumor effect on oral cancer
and KB cells in vitro and in vivo. Oral Oncol. 45:562–568. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Leuenroth SJ and Crews CM:
Triptolide-induced transcriptional arrest is associated with
changes in nuclear substructure. Cancer Res. 68:5257–5266. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Johnson SM, Wang XF and Evers BM:
Triptolide inhibits proliferation and migration of colon cancer
cells by inhibition of cell cycle regulators and cytokine
receptors. J Surg Res. 168:197–205. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Kang DW, Lee JY, Oh DH, et al:
Triptolide-induced suppression of phospholipase D expression
inhibits proliferation of MDA-MB-231 breast cancer cells. Exp Mol
Med. 41:678–685. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Li W, Liu Y, Yu Y, et al: MAPKs are not
involved in triptolide-induced cell growth inhibition and apoptosis
in prostate cancer cell lines with different p53 status. Planta
Med. 77:27–31. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Matsui Y, Watanabe J, Ikegawa M, Kamoto T,
Ogawa O and Nishiyama H: Cancer-specific enhancement of
cisplatin-induced cytotoxicity with triptolide through an
interaction of inactivated glycogen synthase kinase-3β with p53.
Oncogene. 27:4603–4614. 2008.PubMed/NCBI
|
|
11
|
Meng HT, Zhu L, Ni WM, You LS, Jin J and
Qian WB: Triptolide inhibits the proliferation of cells from
lymphocytic leukemic cell lines in association with downregulation
of NF-κB activity and miR-16-1*. Acta Pharmacol Sin. 32:503–511.
2011.PubMed/NCBI
|
|
12
|
Yu C, Zhi-hua S, Qiang W and Jian Z:
Effects of tirptolide on endometrial cancer in human HEC-1B cells.
Prog Obstet Gynecol. 18:282–285. 2009.
|
|
13
|
Jian Z, Zhi-hua S, Qiang W and Yu C:
Growth inhibition effect of triptolide on human endometrial cancer
cells in vivo. Acta Universitatis Medicinalis Nanjing. 29:775–778.
2009.
|
|
14
|
Xiao-hao H, Zhi-hua S and Qiang W: The
effect of triptolide on proliferation and apoptosis signal
transduction pathway-PI3K/PKB in human endometrial carcinoma cell
line. Acta Universitatis Medicinalis Nanjing. 30:910–913. 2010.
|
|
15
|
Baskic D, Popovic S, Ristic P and
Arsenijevic N: Analysis of cycloheximide-induced apoptosis in human
leukocytes: fluorescence microscopy using annexin V/propidium
iodide versus acridin orange/ethidium bromide. Cell Biol Int.
30:924–932. 2006. View Article : Google Scholar
|
|
16
|
Tong JS, Zhang QH, Huang X, et al:
Icaritin causes sustained ERK1/2 activation and induces apoptosis
in human endometrial cancer cells. Plos One. 6:e167812011.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Wilkins RC, Kutzner BC, Truong M,
Sanchez-Dardon J and McLean JRN: Analysis of radiation-induced
apoptosis in human lymphocytes: flow cytometry using Annexin V and
propidium iodide versus the neutral comet assay. Cytometry.
48:14–19. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Yang JS, Chung JG, Wu PP, et al:
Triptolide induces apoptosis in human adrenal cancer NCI-H295 cells
through a mitochondrial-dependent pathway. Oncol Rep. 25:551–557.
2011.PubMed/NCBI
|
|
19
|
Cotter TG: Apoptosis and cancer: the
genesis of a research field. Nat Rev Cancer. 9:501–507. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Sasi N, Hwang M, Jaboin J, Csiki I and Lu
B: Regulated cell death pathways: new twists in modulation of BCL2
family function. Mol Cancer Ther. 8:1421–1429. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Xu B, Guo XX, Mathew S, Armesilla AL,
Cassidy J, Darling JL and Wang WG: Triptolide simultaneously
induces reactive oxygen species, inhibits NF-κB activity and
sensitizes 5-fluorouracil in colorectal cancer cell lines. Cancer
Lett. 291:200–208. 2010.PubMed/NCBI
|
|
22
|
Antonsson B: Bax and other pro-apoptotic
Bcl-2 family ‘killer-proteins’ and their victim the mitochondrion.
Cell Tissue Res. 306:347–361. 2001.
|
|
23
|
Kuhar M, Sen S and Singh N: Role of
mitochondria in quercetin-enhanced chemotherapeutic response in
human non-small cell lung carcinoma H-520 cells. Anticancer Res.
26:1297–1303. 2006.PubMed/NCBI
|
|
24
|
Kim MJ, Lee TH, Kim SH, Choi YJ, Heo J and
Kim YH: Triptolide inactivates Akt and induces caspase-dependent
death in cervical cancer cells via the mitochondrial pathway. Int J
Oncol. 37:1177–1185. 2010.PubMed/NCBI
|
|
25
|
Yang M, Huang J, Pan HZ and Jin J:
Triptolide overcomes dexamethasone resistance and enhanced
PS-341-induced apoptosis via PI3k/Akt/NF-κB pathways in human
multiple myeloma cells. Int J Mol Med. 22:489–496. 2008.PubMed/NCBI
|
|
26
|
Cory S and Adams JM: The bcl2 family:
regulators of the cellular life-or-death switch. Nat Rev Cancer.
2:647–656. 2002. View
Article : Google Scholar : PubMed/NCBI
|
|
27
|
Phillips PA, Dudeja V, McCarroll JA, et
al: Triptolide induces pancreatic cancer cell death via inhibition
of heat shock protein 70. Cancer Res. 67:9407–9416. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Zhu W, Hu H, Qiu P and Yan GM: Triptolide
induces apoptosis in human anaplastic thyroid carcinoma cells by a
p53-independent but NF-κB-related mechanism. Oncol Rep.
22:1397–1401. 2009.PubMed/NCBI
|
|
29
|
Yao JC, Jiang ZZ, Duan WG, et al:
Involvement of mitochondrial pathway in triptolide-induced
cytotoxicity in human normal liver L-02 cells. Biol Pharm Bull.
31:592–597. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Wan CK, Wang C, Cheung HY, Yang M and Fong
WF: Triptolide induces Bcl-2 cleavage and mitochondria dependent
apoptosis in p53-deficient HL-60 cells. Cancer Lett. 241:31–41.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Carter BZ, Mak DH, Schober WD, et al:
Triptolide sensitizes AML cells to TRAIL-induced apoptosis via
decrease of XIAP and p53-mediated increase of DR5. Blood.
111:3742–3750. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Amundson SA, Myers TG and Fornace AJ Jr:
Roles for p53 in growth arrest and apoptosis: putting on the brakes
after genotoxic stress. Oncogene. 17:3287–3299. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Mano Y, Kikuchi Y, Yamamoto K, et al:
Bcl-2 as a predictor of chemosensitivity and prognosis in primary
epithelial ovarian cancer. Eur J Cancer. 35:1214–1219. 1999.
View Article : Google Scholar : PubMed/NCBI
|
